Newswise — Of the more than 38 million Americans who experience migraine headaches, 28 million are women. Compared to men, women also experience more frequent and severe migraines and don’t respond as well to drug treatments. Findings from a new study conducted in rats reveal that females may be more susceptible to migraines and less responsive to treatment because of the way fluctuations in the hormone estrogen affect cells in the brain.
Emily Galloway, an undergraduate research assistant in the laboratory of Tally Largent-Milnes in the Department of Pharmacology at the University of Arizona in Tucson, will present this research at the American Society for Biochemistry and Molecular Biology annual meeting during the 2018 Experimental Biology meeting to be held April 21-25 in San Diego.
“Conducting research on the molecular mechanisms behind migraine is the first step in creating more targeted drugs to treat this condition, for men and women,” said Galloway. “Knowledge gained from this work could lead to relief for millions of those who suffer from migraines and identify individuals who may have better responses to specific therapies.”
The new study is one of the first to examine the role of the sodium proton exchanger NHE1 in migraine headaches. NHE1 regulates the transport of protons and sodium ions across cell membranes, including those that make up the blood-brain barrier. When NHE1 isn’t present at high enough levels or doesn’t function properly, it can cause increased pain signaling that leads to a migraine. Problems with NHE1 can also directly alter the ability of migraine drugs to cross the blood-brain barrier.
Even though women are much more likely to experience migraines than men, most migraine research is conducted using male animal models. In the new study, the researchers examined both male and female rats and found NHE1 expression levels were four times higher in the brains of the male rats. In the female rats, they observed that the highest estrogen levels corresponded with the lowest levels of NHE1 expressed in the endothelial cells that form the blood vessels in the brain.
“Based on our findings, we think that women are more susceptible to migraine because the larger magnitude sex hormone fluctuations lead to changes in NHE1 expression, which may leave the brain vulnerable to ion dysregulation and pain activation,” said Galloway.
The new work is part of an effort to create a molecular map of how sex hormones affect NHE1 expression. In the future, the researchers want to see if drugs that target certain players in this map would prevent dysregulation of NHE1 expression at the blood brain barrier. This could lead to new treatments for people who suffer from migraines.
Emily Galloway will present the findings during the Signal Transduction and Cellular Regulation Session from 12:15–1:00 p.m. Sunday, April 22, in Exhibit Halls A-D, San Diego Convention Center (poster B291 553.60) (abstract). Contact the media team for more information or to obtain a free press pass to attend the meeting.
About Experimental Biology 2018
Experimental Biology is an annual meeting comprised of more than 14,000 scientists and exhibitors from five host societies and multiple guest societies. With a mission to share the newest scientific concepts and research findings shaping clinical advances, the meeting offers an unparalleled opportunity for exchange among scientists from across the United States and the world who represent dozens of scientific areas, from laboratory to translational to clinical research.
About the American Society for Biochemistry and Molecular Biology (ASBMB)
ASBMB is a nonprofit scientific and educational organization with more than 12,000 members worldwide. Founded in 1906 to advance the science of biochemistry and molecular biology, the society publishes three peer-reviewed journals, advocates for funding of basic research and education, supports science education at all levels, and promotes the diversity of individuals entering the scientific workforce. www.asbmb.org
Find more news briefs and tipsheets at: https://www.eurekalert.org/meetings/eb/2018/newsroom/